| |
Efficiency & productivity in biologics manufacturing is a longstanding goal, as increasingly complex molecules transform approaches to drug development. Process intensification, with advanced techniques & high productivity platforms, accelerates this pace of innovation. Read white paper. .png)
|
|
Today's Big NewsJul 28, 2023 |
|
Thursday, August 3, 2023 | 11am ET / 8am PT Join us for this insightful discussion on how to unlock the full potential of liquid biopsy and be an integral part of the future of precision medicine. We’ll take a deep dive into the latest strategies and solutions designed to help overcome current challenges and empower researchers and clinicians with enhanced capabilities. Register now. 
|
|
| By Kevin Dunleavy Biogen has revealed a proposal to acquire Reata Pharmaceuticals for $7.3 billion. The Texas-based rare disease specialist brings newly approved Skyclarys, the first treatment for the neurologic disorder Friedreich’s ataxia with peak sales potential of $1.5 billion. |
|
|
|
| Philadelphia, PA |  |
|
|
By Max Bayer The FDA has a better idea of the data they need to grant accelerated approvals for rare disease drugs, meaning more could soon see the light of day, according to Peter Marks, M.D., Ph.D. |
By Andrea Park “Q2 was our highest revenue quarter ever and represented the largest year-over-year dollar growth in our company's history,” Dexcom CEO Kevin Sayer said in a call with investors. |
By Nick Paul Taylor It’s all change at AstraZeneca. The Anglo-Swedish drugmaker not only revealed its second quarter earnings results, but also disclosed the elimination of several pipeline programs, the purchase of a portfolio of preclinical gene therapies from Pfizer and the upcoming departure of a key, long-serving R&D executive. |
|
Wednesday, September 6, 2023 | 2:00 PM ET / 11:00 AM PT Attendees will learn about tools for interacting with medical images, guiding readers through labeling workflows, and streamlining adjudication and data standardization. Real-world use cases of how pharma companies are enhancing AI development by optimizing reader workflows will be discussed. Register now. 
|
|
By Andrea Park GE HealthCare warned healthcare providers that tens of thousands of TruSignal pulse oximeters may put hospitalized patients at risk of further injury. |
By Nick Paul Taylor Sanofi and BioNTech’s vision of using mRNA to prime anti-cancer immune attacks has failed to hold up to clinical scrutiny. After running an interim analysis of early-phase data, the partners have jointly decided (PDF) to scrap development of the candidate as an intratumoral therapy. |
By Angus Liu Is AstraZeneca planning to peel off its China business? By CEO Pascal Soriot’s response to that question, it may only be a contingency plan. |
By Fraiser Kansteiner Teva has enlisted BeiGene's Angus Grant, Ph.D. as its EVP of business development, the Israeli-American generics giant announced Friday. It was during Grant's tenure as chief business executive that BeiGene signed the high-profile PD-1 and TIGIT pacts with Novartis. |
By Conor Hale Abbott has reported 26 incidents to the FDA, including 16 injuries and zero deaths. |
By Teresa Carey This week on "The Top Line," we revisit an episode on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we revisit an episode on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription. |
|
|---|
|
|
|
Thursday, August 17, 2023 | 11am ET / 8am PT In this webinar, we will discuss the challenges and opportunities for WGBS in an era of cost-effective sequencing: Optimizing protocols and reagents for consistent and reliable results, establishing community standards to ensure WGBS library quality, and more. Register now.
|
|
Webinar Download this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
Whitepaper Learn more about the current challenges and issues that eClinical technology providers are facing. Sponsored by: YPrime |
Research The right sourcing strategy can help save of millions of dollars—learn about developing a strategy for sourcing the cGMP chemicals critical to your processes. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
Whitepaper Learn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
eBook This eBook identifies the trends driving major change in the Medical Affairs (MA) function. It also outlines the strategic and tactical implications for MA leaders and team members. Sponsored by: Blue Matter, strategic consultants in the life sciences |
eBook Take a look at the reporting tools sponsors need to access insights earlier in the clinical trial enrollment funnel, so you can take informed actions. Sponsored by: OneStudyTeam |
Whitepaper Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your bioprocessing workflows. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| |
|
